Furthermore, the loss of function assay revealed that knockdown of lncTCF7 significantly inhibited glioma cell migration, proliferation and tumorigenicity through upregulating E-cadherin or suppressing TCF7/Sox2 and CyclinD1 expression. The gene discussed is SOX2; the disease is central nervous system cancer.